Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Science Corp makes brain-computer interfaces and retinal implants that help people with blindness and neurological conditions see and move again.
COMPANY_COMMON_NAME: Science Corp
Science Corp is a neurotechnology company building brain-computer interfaces and retinal implants — tiny devices that connect the human nervous system to machines. Its most famous product is a retinal implant for people who have lost their sight, designed to restore a form of vision by stimulating the eye's remaining cells. The company also develops interfaces aimed at neurological conditions affecting movement. The business is not a consumer gadget shop. It sells to patients with blindness and neurological disorders, typically through surgeons and clinical care channels, and it earns money from selling those implant systems and the procedures around them. Customers choose it because the alternative is often nothing — for many patients with severe vision loss, there is no mainstream cure, so a device that restores even partial sight is a powerful draw. Science Corp has an unusual origin. It was founded by Max Hodak, a co-founder of Neuralink — though Neuralink is private, so no ticker marker — after he left that company. That pedigree gave Science Corp credibility and capital in a field where the science is hard and the timelines are long. The company has raised significant venture funding and acquired at least one other vision-focused neurotech firm to speed up its path to patients.
The bet here is big and risky. Brain-computer interfaces are still early, regulation is strict, and proving a device is safe and effective takes years. But if Science Corp gets its implants into enough patients and keeps improving them, it could become the default name in restoring sight and movement — a rare thing in medicine: a product that gives back something people thought they had lost for good.
Saved answer · last researched 15 Nov 2026